Fig. 1 · Structure
Documents & Downloads
Tegafur-gimeracil-oteracil potassium
Anticancer Agent
Tegafur-gimeracil-oteracil potassium is an oral anticancer agent that combines Tegafur, Gimeracil, and Oteracil potassium in a molar ratio of 1:0.4:1. This compound exhibits significant biological activity in inhibiting tumor growth and is predominantly applied in research related to gastric cancer, particularly in studies of peritoneal dissemination. Its unique combination of components enhances its efficacy in targeting cancer cells, making it a valuable tool for oncological research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 150863-82-4 |
| Applications | Anticancer Agent |
| Formula | C17H15ClFKN6O9 |
| Molecular Weight | 540.89 |
| Synonyms | S-1; TS-1 |
| SMILES | O=C(C1=NC(NC(N1)=O)=O)O[K].O=C2C=C(C(Cl)=CN2)O.O=C3NC(N(C4OCCC4)C=C3F)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.